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ABSTRACT

Fluorescent dyes and probes are key components in multiphoton based fluorescence microscopy imaging of biological samples. In order to address the demand for better
performing dyes for two-photon based imaging, a new series
of reactive fluorophores tailored for multiphoton imaging
has been disclosed. These fluorophores are based upon the
fluorene ring system, known to exhibit high fluorescence
quantum yields, typically >0.7, and possess high photostability. They have been functionalized with moieties to act,
e.g., as efficient amine-reactive fluorescent probes for the
covalent attachment onto, e.g., proteins and antibodies. The
synthesis and the single-photon spectral characteristics, as
well as measured two-photon absorption cross sections of
the reactive fluorophores in solution are presented. Spectral
characterizations of bovine serum albumin (BSA) conjugated with the new reactive probe is presented.
3 Claims, 6 Drawing Sheets
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REACTIVE PROBES FOR TWO-PHOTON
FLUORESCENT IMAGING AND SENSING

It would be highly desirable to provide a two-photon
probe with the properties of high fluorescence quantum
yields, of high photon absorptivity and high photo stability.

This is a Divisional of application Ser. No. 11/128,497
filed May 13, 2005 now U.S. Pat. No. 7,253,287 which
claims the benefit of priority to U.S. Provisional Patent
Application No.: 60/571,202 filed May 14, 2004.

SUMMARY OF THE INVENTION

FIELD OF INVENTION
10

This invention relates to two-photon fluorescence imaging, and in particular to a class of fluorescence pro bes having
the properties of high fluorescence quantum yields, high
photon absorptivity and high photostability.
15

BACKGROUND AND PRIOR ART
Two-photon laser scanning fluorescence microscopy, first
demonstrated by Denk et al. in 1990, is based on the
simultaneous absorption of two low-energy photons by a
fluorophore in a single quantum event to induce an electronic excitation that is normally accomplished by a single
high-energy photon. The main advantage of two-photon
microscopy over conventional linear microscopy stems from
the high spatial localization of this excitation event due to
the quadratic relation between the excitation and illumination intensity. Practically, this means fluorescence occurs
only at the beam focus and as ultrafast, pulsed, near-IR laser
irradiation is used as the excitation source, deeper imaging
into optically thick tissue, with restricted photobleaching
and phototoxicity to the exposed area of the specimen is
achieved. The tenants of two-photon absorption (2PA)
enables investigations of complex biological problems and
experiments on living samples not possible with other
imaging techniques, and highlighted examples of its use in
the medicinal and biological research areas have been noted.
Two-photon fluorescence methods and techniques have
advanced to yield sophisticated imaging techniques, but
conventional UV-excitable fluorophores not optimized for
efficient 2PA continue to be utilized. Two-photon photophysical characterization databases for commonly used fluorophores and bio-indicators have been reported. Many of
these compounds exhibit relatively low two-photon absorption cross-sections (1\), on the order of 10 to 100 GM units.
The (1\) parameter is an indicator of the two-photon absorption efficiency, and only recently has research been reported
on the design and development of very efficient 2PA dyes on
the order of >10 GM units. Much of the synthetic efforts
have focused on preparing new organic dyes for a range of
applications, as molecules specifically engineered for twophoton excitation may significantly outperform standard
fluorophores optimized for single photon excitation. However, the identification and availability of optimized 2PA
fluorophores specifically tailored for labeling biomolecules
for two-photon fluorescence imaging studies are rare. To
date, reactive fluorescent dyes exhibiting high 2PA crosssections, specifically to covalently modify biomolecules
have not been reported. Hence, the need to incorporate
reactive, efficient 2PA fluorophores for covalent attachment
onto biomolecules within the fluorophore design strategy
seems timely and fulfills an appropriate need which coincides with increasing usage of two-photon excitation fluorescence imaging applications in the life sciences.
Previous studies have reported on the design and development of fluorene-based organic dyes with very efficient
two-photon absorption and fluorescence emission properties
and their use in data storage and sensing applications.

20

The primary objective of this invention is to provide a
two-photon probe with the property of high fluorescence
quantum yields.
The secondary objective of this invention is to provide a
two-photon probe with the property of high photon absorptivity.
The third objective of this invention is to provide a
two-photon probe with the property of high photostability.
Novel two-photon probes according to this invention are
used in a method of multiphon imaging comprising the use
of reactive fluorophores having a fluorene ring system
wherein said fluorophores are functionalized with moieties
having the properties of covalent attachment onto proteins,
antibodies, DNA, and RNA.
In the present invention, a preferred reactive fluorophore
has the structural formula
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rJJ

SCN

s
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and a preferred dye adduct has the structural formula:
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A BSA model bioconjugate has the structural formula
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and a hydrophilic amine-reactive fluorophore has the structural formula

HOOC
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65

in the present invention.
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A more preferred dye adduct of the present invention is
hydrophilic and has the structural formula

R3 is independently amino, hydroxy, halogen, C 1-C 6
alkoxy, C 1-C 10 alkyl, C 1-C 6 haloalkyl, SH, SCH 3 , -NH(C 1C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH(aryl), -N(aryl) 2 ,
-NHCO(C 1-C4 alkyl), -N=C=S, -NH(C=S)-O(C1C 6 alkyl), -NH(C=S)-NH(C 1-C 6 alkyl), -NH(C=S)N(C1 -C 6 alkyl) 2 , ---C0 2 H, or -C0 2 (C 1-C6 alkyl).
To more fully understand the scope of the above reaction
products, a preferred two-photon fluorophore labeled protein
or antibody of the present invention is provided below.
A preferred two-photon fluorophore labeled protein of the
present invention has the formula

ROOC

COOR

5

R
R
/N~N
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II

10

s
A preferred hydrophilic protein bioconjugate of the
present invention has the structural formula
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A preferred method of multiphon imaging includes the
use of reactive fluorophores upon a fluorene ring system,
more preferably, the fluorophores are functionalized with
moieties having the properties of covalent attachment onto
proteins and antibodies.
It is also preferred that a Ti:sapphire laser be used to
provide for the multiphoton imaging.
A preferred generic Two-Photon Reactive Probe Structure
has the formula

25

30

35

x

y
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40

R 1, R 2 , X, and Y are all functionality tailored for specific
applications
wherein R 1 and R 2 are selected from the group, such that R 1
and R 2 , at each occurrence, are independently C 1-C 16
alkyl, C 1-C 10 haloalky, -(CH 2 ) 1_9 C0 2 H, -(CH,) 1_9 C0 2
(C 1-C 6 alkyl), -(CH 2 CH 2 0) 1_10 H, -(CH2CH 2 0) 1_10
(C 1-C 6 alkyl); -(CH 2 CH 2 0) 1_10 (C0 2 C 1-C 6 alkyl);
-(CH 2 CH 2 0) 1_10 (C0 2 H); or -(CH 2 CH 2 0) 1_10 (C0 2 N-succinimidyl);
X is selected from the group:
-N=C=S, -N=C=O, C0 2 H, -N-succinimidyl,
-P(=O)(OH) 2 ,
-P(=O)(OH)(O---C 1-C 6
alkyl),
-P(=O)Cl 2 , P(=O)F 2 , -P(=O)(F)(O---C 1-C 6 alkyl),
-P(=O)(Cl)(O-C1-C 6 alkyl), P(=O)Br2 , or -P(=O)
(Br)(O---C 1-C 6 alkyl);
wherein Y is selected from the group:
-NH 2 , -NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH
(aryl), -N(aryl) 2 , -NHCO(C 1-C4 alkyl), 2-thiazolyl
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl substituted with 0-4
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and
N-carbazolyl substituted with 0-4 R3 ; and

45

wherein R 1 and R 2 are selected from the group:
R 1 and R 2 , at each occurrence, are independently C 1-C 16
alkyl, C 1-C 10 haloalky, -(CH 2 ) 1_9 C0 2 H, -(CH,) 1_9 C0 2
(C 1-C 6 alkyl), -(CH 2 CH 2 0) 1_10 H, -(CH2CH 2 0) 1_10 (C 1C 6 alkyl);
-(CH 2 CH 2 0) 1_10 (C0 2
C 1-C 6 alkyl);
-(CH 2 CH 2 0) 1_10 (C0 2 H); or -(CH 2 CH 2 0) 1_10 (C0 2 -Nsuccinimidyl);
wherein Y is selected from the group:
-NH 2 , -NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH
(aryl), -N(aryl) 2 , -NHCO(C 1-C4 alkyl), 2-thiazolyl substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 R3 ;
2-benzothiazolyl substituted with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl substituted with 0-4 R3 ; and 2- or
4-pyridyl substituted with 0-4 R3 , and N-carbazolyl substituted with 0-4 R3 ; and
R3 is independently amino, hydroxy, halogen, C 1-C 6
alkoxy, C 1-C 10 alkyl, C 1-C 6 haloalkyl, SH, SCH 3 , -NH(C 1C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH(aryl), -N(aryl) 2 ,
-NHCO(C 1-C4 alkyl), -N=C=S, -NH(C=S)-O(C1C6 alkyl), -NH(C=S)-NH(C 1-C 6 alkyl), -NH(C=S)N(C1 -C 6 alkyl) 2 , ---C0 2 H, or ---C0 2 (C 1-C 6 alkyl).
The present invention also includes a preferred twophoton fluorophore labeled antibody having the formula

R

50

N

Antibody...,,,,,./

y

R

N

:y

s
55

6

°

65

wherein R 1 and R 2 are selected from the group:
R 1 and R 2 , at each occurrence, are independently C 1-C 16
alkyl, C 1-C 10 haloalky, -(CH 2 ) 1_9 C0 2 H, -(CH,) 1_9 C0 2
(C 1-C 6 alkyl), -(CH 2 CH 2 0) 1_10 H, -(CH2CH 2 0) 1_10 (C 1C 6 alkyl);
-(CH 2 CH 2 0) 1_10 (C0 2
C 1-C 6 alkyl);
-(CH 2 CH 2 0) 1_10 (C0 2 H); or -(CH 2 CH 2 0) 1_10 (C0 2 -Nsuccinimidyl);
wherein Y is selected from the group:
-NH 2 , -NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH
(aryl), -N(aryl) 2 , -NHCO(C 1-C4 alkyl), 2-thiazolyl substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 R3 ;
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2-benzothiazolyl substituted with 0-4 R 3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl substituted with 0-4 R 3 ; and 2- or
4-pyridyl substituted with 0-4 R 3 , and N-carbazolyl substituted with 0-4 R 3 ; and
R3 is independently amino, hydroxy, halogen, C 1 -C 6
alkoxy, C 1 -C 10 alkyl, C 1 -C 6 haloalkyl, SH, SCH 3 , -NH(C 1C 6 alkyl), -N(C 1 -C 6 alkyl) 2 , -NH(aryl), -N(aryl) 2 ,
-NHCO(C 1-C4 alkyl), -N=C=S, -NH(C=S)--O(C 1C6 alkyl), -NH(C=S)-NH(C 1 -C 6 alkyl), -NH(C=S)N(C 1 -C 6 alkyl) 2 , --C0 2 H, or -C0 2 (C 1 -C 6 alkyl).
Further objects and advantages of this invention will be
apparent from the following detailed description of the
presently preferred embodiments which are described in the
following text.

EXPERIMENTAL

5

10

15

BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 shows the preparation of a dye adduct and model
bioconjugate with a reactive 2PA fluorophore.
FIG. 2 shows the preparation of a model bioconjugate
with reactive fluorophore
FIG. 3 shows the structure of a hydrophilic aminereactive fluorophore (4) for the preparation of a model
adduct and bioconjugate.
FIG. 4 shows normalized UV-visible absorbance (1, 2)
and fluorescence emission (1', 2'; excitation line indicated)
spectra of the reactive fluorophore 1 and the dye adduct 2.
FIG. Sa shows the two-photon absorption for the dye
adduct.
FIG. Sb shows a log-log plot of the dye adduct integrated
fluorescence.
FIG. 6 shows normalized absorption spectra of the free
BSA protein and BSA-dye conjugate (1 and 2) and steadystate fluorescence emission spectrum of the BSA-dye conjugate (2').
FIG. 7 is an example of an amine reactive two-photon
fluorescent probe of the present invention.

Reference should now be made to FIG. 1. The synthesis
of an amine reactive fluorescent dye (1) was prepared as a
biological labeling probe (Scheme 1). Intermediate compounds A-F have been described previously in the literature.
Preparation of reactive probe 1, from aminofluorene F, was
performed quantitatively, following the literature protocol.
The procedure for preparation of reactive probe 1 is shown
in FIG. 1. Compound (1) was prepared as an amine-reactive
fluorescent dye, containing the isothiocyanate functionality
that can react with primary amine groups present on protein
molecules. A model dye-adduct (2) was also prepared by
reacting (1) with an-butyl-amine to test its reactivity as an
amine-reactive fluorescent label (FIG. 1). Preparation of the
model adduct allowed for facile single- and two-photon
spectroscopic characterizations that more closely resembles
the bioconjugate than that of the reactive fluorophore alone.

20

25

A

30

02N

KOH, KI
BrC10H21, 25' C.
DMSO

35

B
C10H21

C10H21

40

c
1. n-BuLi, -75' C., THF
2. n-Bu3SnCl, -75° C. -r.t.

DETAILED DESCRIPTION OF THE
INVENTION
Before explaining the disclosed embodiment of the
present invention in detail it is to be understood that the
invention is not limited in its application to the details of the
particular arrangement shown since the invention is capable
of other embodiments. Also, the terminology used herein is
for the purpose of description and not of limitation.
To better understand this invention set forth, recall that the
fluorene ring is a II-conjugated system which allows for
facile synthetic manipulation, yielding dyes with tailored
spectral properties. Efforts directed towards preparing reactive fluorescent dyes have been initiated with the synthesis
of an amine-reactive dye for labeling, e.g., lysine residues on
proteins. A model dye-adduct exhibiting high fluorescence
quantum yield (QY=0.74) was also prepared by reacting an
amine-reactive dye with n-butyl-amine to test its reactivity
as an amine-reactive fluorescent label and determine its
spectroscopic properties. Additionally, a model protein bioconjugate was prepared with the reactive fluorophore and
bovine serum albumin. Finally, a hydrophilic derivative of
an amine-reactive dye was prepared to obtain a more watersoluble dye. The foregoing will become apparent upon
reading the following experimental discussion.

50

55

60

65

The amine-reactive fluorescent dye (1) was used to prepare
a bioconjugate (3) with bovine serum albumin (BSA) protein as a model biomolecule (which is shown in FIG. 2). The
use of BSA, an inexpensive protein that has been extensively
characterized, is ideal for establishing optimal conditions to
obtain a model bioconjugate allowing for subsequent spectroscopic characterization.
The amine reactive reagent (isothiocyanate functional
group) reacts with non-protonated aliphatic amine groups,
including the N-terminus of proteins and the E-amino groups
oflysines (pKa,.,10.5). A typical protocol for the conjugation
was followed in an amine-free buffer with a slightly basic
pH (pH=9.0). The amine reactive dye (1) was dissolved in
DMSO, immediately prior to addition into the stirring BSA
protein solution. The reaction mixture was allowed to stir at

US 7,282,514 Bl
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room temperature, after which it was passed through a
Sephadex G-25 gel filtration column pre-swollen with water
and equilibrated with phosphate buffer saline (PBS, pH 7 .2)
solution. Small fractions, eluted with the PBS solution were
collected into sterile plastic tubes, and the UV-visible
absorption and steady-state fluorescence emission spectra of
the bioconjugate were obtained.
Two different molar ratios of the reactive dye to protein
were performed to assess the reactivity of the dye for its
degree of labeling (DOL) (Table 1). The degree of labeling
was estimated using average values from standard equations
obtained from reference 25.

FIGS. Sa-Sb show the two-photon cross section of the dye
adduct in FIG. Sa, and the log-log plot of its integrated
fluorescence as a function of pump power variation at two
different fs excitation wavelengths in FIG. Sb.

TABLE 1

10

15

Variable degree of labeling obtained by changing the molar
ratios of the reactive dye to BSA.

BSA

Reactive
fluorophore

Dye:Protein
mol ratio

Reaction
time

DOL (mol dye:
mol protein)

1.53E-8 mol
1.53E-8 mol
1.53E-8 mol

1.53E-7 mol
7.7E-8 mol
7.7E-8 mol

10:1
5:1
5:1

1h
1h
2h

3.4
2.4
2.2

20

25

RESULTS AND DISCUSSION OF THE
INVENTION
The normalized UV-visible absorption and steady-state
fluorescence emission spectra of the free reactive fluorophore (1) and the dye adduct (2) in DMSO are shown in FIG.
4. The free reactive fluorophore exhibits two absorption
maxima at approximately 357 and approximately 375 nm,
along with two emission maxima at approximately 384 and
approximately 404 nm. The dye adduct instead exhibits a
single absorption maximum at approximately 363 nm with
an emission maximum at approximately 403 nm, and is well
resolved from that of its absorption spectrum, with minimal
spectral overlap. The fluoroscence quantum yield (Rhadamine 6G in ethanol as a standard) of the reactive fluorophore in DMSO was approximately 0.02, while that of the
dye adduct in DMSO increased significantly to approximately 0.74, indicating the fluorescence of the reactive dye
should be restored upon conjugation to a biomolecule.
The two-photon absorption cross sections (from twophoton fluorescence measurements) for the dye adduct in
DMSO was obtained under femtosecond (fs) near IR irradiation (FIG. Sa). The linear, single photon absorption
spectrum is shown as the line profile, while the two-photon
absorption cross sections were measured at wavelengths that
were twice that of the linear absorption, and are shown as the
data points. The y-axis is shown as two near-IR photons used
to obtain the cross section converted to an equivalent single
proton wavelength. The two-photon absorption cross section
at the energy of the linear absorption maximum near 3 70 nm
is approximately 25 GM units. Interestingly, while the linear
absorption spectrum for the compound does not display any
significant absorption at the shorter wavelengths, the value
of the two-photon absorption cross section increases. To
ensure the dye adduct undergoes 2PA, a log-log plot of the
fs pump power to that of the integrated fluorescence was
constructed. As can be seen from FIG. Sb, the slopes from
the measurements confirm the quadratic dependence characteristic of fluorescence obtained from two-photon absorpti on.
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35

40
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The normalized absorption and steady-state fluorescence
emission spectra of the BSA-dye bioconjugate (3) in PBS
buffer (pH 7.2) is shown in FIG. 6. For reference, the
absorption spectrum of the free BSA protein in PBS solution
is also shown. The BSA-dye conjugate displays absorption
peaks corresponding to that of the BSA protein in the shorter
wavelength range (omax=280 nm), as welll as that of the
fluorescence em1ss10n of longer absorption range
(omaxuma =360 nm and 380 nm). The fluorescence emission
of the bioconjugate is broad and exhibits an appreciable
Stoke's shift. An appreciable bathochromic shift in the
fluorescence emission was observed in the BSA-dye conjugate relative to that of the free reactive fluorophore, and with
a similar broadening observed in the absorption profile, the
fluorescence emission was also broader than that of the free
fluorophore. The observed Stoke's shift in the free dye was
about 45 nm, while that of the BSA-dye conjugate was much
greater (Stoke's shift=73 nm upon oex=360 nm, and 53 nm
upon oex=380 nm). The fluorescence emission profile of the
BSA-dye conjugate upon excitation at oex=360 nm and
oex=380 nm yielded similar fluorescence intensities.
The spectroscopic profiles of the BSA-dye conjugate
validate the use of the reactive dye (1) to form bioconjugates
with protein biomolecules for fluorescence imaging applications. However, attempts to conjugate the dye onto an
anti-BSA antibody (Molecular Probes) were unsuccessful.
The two hydrophobic alkyl chains on the fluorene ring may
have interfered with efficient conjugation onto the higher
molecular weight of the antibody (-150 kDa) relative to that
of the smaller protein (-65 kDa ). Hence, a more hydrophilic
derivative of an amine-reactive dye was prepared (compound 4 of FIG. 3). Substitution of the alkyl groups on the
fluorene ring with carboxylates should enhance the water
solubility of the reactive dye, and is expected to improve its
conjugation to a wider range of biomolecules in aqueous
media. The FT-IR spectrum of the hydrophilic reactive dye
(4) displayed a strong NCS stretch at 2118 cm-1, indicating
the presence of the amine-reactive functionality. Efforts to
prepare appropriate adducts and bioconjugates with the
hydrophilic dye (4) are currently underway.
A new series of reactive flurophores have been prepared
to covalently label biomolecules for multiphoton imaging.
These fluorphores are based upon the fluorene ring system
and exhibit high fluorescence quantum yields upon bioconjugation (-0.7). They have been functionalized with moieties to act, e.g., as efficient amine-reactive fluorescent
probes for the convalent attachment onto, e.g., proteins and
antibodies. A bovine serum albumin (BSA) conjugate with
a new reactive probe has been demonstrated. Additionally, a
hydrophilic reactive fluorophore has been prepared,
expected to be more efficient for labeling biomaterials in
aqueous media. These efficient two-photon absorbing reactive dyes are expected to be versatile probes for multiphoton
bio-imaging applications.
In summary, there is disclosed numerous structures and
the preparation provided by the teachings of this invention:
the dye adduct
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A hydrophilic amine-reactive fluorophore having the structural formula
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HOOC
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H
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s

s

4

15

s

Hydrophilic Reactive Dye

2
Dye Addict (Model Compound)

The dye adducts that are hydrophilic and have the structural
formulae

20

Generic Two-Photon Reactive Probe Structure
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A BSA model bioconjugate having the structural formula
45
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s

Model
Protein

Reactive Fluorophore
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x
50

r.t.
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R1, R 2 , X, and Y are all functionality tailored for specific
applications
wherein R 1 and R 2 are selected from the group:
R 1 and R 2 , at each occurrence, are independently C 1 -C 16
alkyl, C 1 -C 10 haloalky, -(CH 2 ) 1 _9 C0 2 H, -(CH,) 1 _9 C0 2
(C 1 -C 6 alkyl), -(CH 2 CH 2 0) 1 _10 H, -(CH2CH 2 0) 1 _10 (C 1 C6
alkyl);
-(CH 2 CH 2 0) 1 _10 (C0 2
C 1 -C 6
alkyl);
-(CH 2 CH 2 0) 1 _10 (C0 2 H); or -(CH 2 CH 2 0) 1 _10 (C0 2 -Nsuccinimidyl);

H
N

s
BSA Model Bioconjugate

65

wherein X is selected from the group:
-N=C=S, -N=C=O, C0 2 H, -N-succinimidyl,
-P(=O)(OH) 2 ,
-P(=O)(OH)(O-C 1 -C 6
alkyl),
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-P(=O)Cl 2 , P(=O)F 2 , -P(=O)(F)(O---C 1-C 6 alkyl),
-P(=O)(Cl)(O-C 1-C 6 alkyl), P(=O)Br2 , or -P(=O)
(Br)(O---C 1-C 6 alkyl);

We claim:
1. A method of multi photon imaging comprising exciting
a two-photon reactive probe structure of the formula:

wherein Y is selected from the group:
-NH 2 , -NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH
(aryl), -N(aryl) 2 , -NHCO(C 1-C4 alkyl), 2-thiazolyl substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2 R3 ;
2-benzothiazolyl substituted with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl substituted with 0-4 R3 ; and 2- or
4-pyridyl substituted with 0-4 R3 , and N-carbazolyl substituted with 0-4 R3 ;
R3 is independently amino, hydroxy, halogen, C 1-C 6
alkoxy, C 1-C 10 alkyl, C 1-C 6 haloalkyl, SH, SCH 3 , -NH(C 1C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH(aryl), -N(aryl) 2 ,
-NHCO(C 1-C4 alkyl), -N=C=S, -NH(C=S)--O(C 1C6 alkyl), -NH(C=S)-NH(C 1-C 6 alkyl), -NH(C=S)N(C1 -C6 alkyl) 2 , ---C0 2 H, or -C0 2 (C 1-C 6 alkyl).
FIG. 7 and the example below are further illustrative of
the scope of this invention as an amine reactive two-photon
fluorescent probe.
Example of an Amine Reactive Two-Photon
Fluorescent Probe

S::::::::,C

rjJ

::::::ON

s

reactive probe

Protein or Antibody

x
10

R1, R 2 , X, and Y are all functionality tailored for specific
applications
15
R 1 and R 2 are selected from the group wherein:
R 1 and R 2 , at each occurrence, are independently C 1-C 16
alkyl,
C 1-C 10
haloalky,
-(CH 2 ) 1_9 C0 2 H,
-(CH 2 ) 1_9 C0 2 (C 1-C 6 alkyl), -(CH 2 CH 2 0) 1_10 H,
-(CH 2 CH 2 0) 1_10 (C 1-C 6 alkyl); -(CH2 CH 2 0) 1_10
20
(C0 2 C 1-C 6 alkyl); -(CH 2 CH 2 0) 1_10 (C0 2 H); or
-(CH 2 CH 2 0) 1_10 (C0 2 -N-succinimidyl);
wherein X is selected from the group:
-N=C=S, -N=C=O, C0 2 H, -N-succinimidyl,
-P(=O)(OH) 2 , -P(=O)(OH)(O---C 1-C 6 alkyl),
25
-P(=O)Cl 2 , P(=O)F 2 , -P(=O)(F)(O-C 1-C 6
alkyl), -P(=O)(Cl)(O---C 1-C 6 alkyl), P(=O)Br2 , or
-P(=O)(Br)(O-C 1-C 6 alkyl);
wherein Y is selected from the group:
-NH 2 , -NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH
30
(aryl), -N(aryl) 2 , -NHCO(C 1-C4 alkyl), 2-thiazolyl
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl substituted with 0-4
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and
35
N-carbazolyl substituted with 0-4 R3 ;
3
R is independently amino, hydroxy, halogen, C 1-C 6
alkoxy, C 1-C 10 alkyl, C 1-C 6 haloalkyl, SH, SCH 3 ,
-NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH(aryl),
-N(aryl) 2 , -NHCO(C 1-C4 alkyl), -N=C=S,
40
-NH(C=S)-O(C 1-C 6 alkyl), -NH(C=S)-NH(C 1C 6 alkyl), -NH(C=S)-N(C 1-C 6 alkyl) 2 , -C0 2 H, or
---C0 2 (C 1-C 6 alkyl);
or a two-photon fluorophore labeled protein of the formula
45

rjJ
s

H
N

50
Protein...,,,..,./

y

H
N

y

s
55

Two-Photon Fluorophore-Labeled Protein or
Antibody
While the invention has been described, disclosed, illustrated and shown in various terms of certain embodiments or
modifications which it has presumed in practice, the scope
of the invention is not intended to be, nor should it be
deemed to be, limited thereby and such other modifications
or embodiments as may be suggested by the teachings herein
are particularly reserved especially as they fall within the
breadth and scope of the claims here appended.

60
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R 1 and R 2 are selected from the group wherein:
R 1 and R 2 , at each occurrence, are independently C 1-C 16
alkyl,
C 1-C 10
haloalky,
-(CH 2 ) 1_9 C0 2 H,
-(CH 2 ) 1_9 C0 2 (C 1-C 6 alkyl), -(CH 2 CH 2 0) 1_10 H,
-(CH2CH 2 0) 1_10 (C 1-C 6 alkyl); -(CH2 CH 2 0) 1_10
(C0 2 C 1-C 6 alkyl); -(CH 2 CH 2 0) 1_10 (C0 2 H); or
-(CH 2 CH 2 0) 1_10 (C0 2 -N-succinimidyl);
wherein Y is selected from the group:
-NH 2 , -NH(C 1-C 6 alkyl), -N(C 1-C 6 alkyl) 2 , -NH
(aryl), -N(aryl) 2 , -NHCO(C 1-C4 alkyl), 2-thiazolyl
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2
R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrlbenzothiazolyl; 2-benzoxazolyl substituted with 0-4
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(C0 2 C 1 -C 6 alkyl); -(CH 2 CH 2 0) 1 _10 (C0 2 H); or
R'; and 2- or 4-pyridyl substituted with 0-4 R3 , and
-(CH 2 CH 2 0) 1 _10 (C0 2 -N-succinimidyl);
N-carbazolyl substituted with 0-4 R3 ;
R3 is independently amino, hydroxy, halogen, C 1 -C 6
wherein Y is selected from the group:
alkoxy, C 1 -C 10 alkyl, C 1 -C 6 haloalkyl, SH, SCH 3 ,
-NH 2 , -NH(C 1 -C 6 alkyl), -N(C 1 -C 6 alkyl) 2 , -NH
-NH(C 1 -C 6 alkyl), -N(C 1 -C 6 alkyl) 2 , -NH(aryl), s
(aryl), -N(aryl) 2 , -NHCO(C 1 -C4 alkyl), 2-thiazolyl
-N(aryl) 2 , -NHCO(C 1 -C4 alkyl), -N=C=S,
substituted with 0-2 R3 ; 2-oxazolyl substituted with 0-2
-NH(C=S)-O(C 1-C 6 alkyl), -NH(C=S)-NH(C 1R3 ; 2-benzothiazolyl substituted with 0-4 R3 ; 2-styrlC 6 alkyl), -NH(C=S)-N(C 1 -C 6 alkyl) 2 , -C0 2 H, or
benzothiazolyl; 2-benzoxazolyl substituted with 0-4
--C0 2 (C 1 -C 6 alkyl);
R3 ; and 2- or 4-pyridyl substituted with 0-4 R3 , and
or a two-photon fluorophore labeled antibody of the formula 10
N-carbazolyl substituted with 0-4 R3 ;
R3 is independently amino, hydroxy, halogen, C 1 -C 6
alkoxy, C 1 -C 10 alkyl, C 1 -C 6 haloalkyl, SH, SCH 3 ,
-NH(C 1 -C 6 alkyl), -N(C 1 -C 6 alkyl) 2 , -NH(aryl),
-N(aryl) 2 , -NHCO(C 1 -C4 alkyl), -N=C=S,
15
-NH(C=S)-O(C 1-C 6 alkyl), -NH(C=S)-NH(C 1H
H
N
N
C 6 alkyl), -NH(C=S)-N(C 1 -C 6 alkyl) 2 , -C0 2 H, or
Protein,..,.,..,/
--C0 2 (C 1 -C 6 alkyl).
s
2. The method according to claim 1 wherein said fluoro20 phores are functionalized with moieties having the properties of covalent attachment onto proteins and antibodies.
R 1 and R 2 are selected from the group wherein:
1
2
3. The method according to claim 1 wherein a Ti:sapphire
R and R , at each occurrence, are independently C 1 -C 16
laser is used to provide for the multiphoton imaging.
alkyl,
C 1 -C 10
haloalky,
-(CH 2 ) 1 _9 C0 2 H,
-(CH 2 ) 1 _9 C0 2 (C 1 -C 6 alkyl), -(CH 2 CH 2 0) 1 _10 H,
-(CH2CH 2 0) 1 _10 (C 1 -C 6 alkyl); -(CH 2 CH 2 0) 1 _10
* * * * *

y

UNITED STATES PATENT AND TRADEMARK OFFICE

CERTIFICATE OF CORRECTION
PATENT NO.
APPLICATION NO.
DATED
INVENTOR(S)

: 7,282,514 Bl
: 11/786290
: October 16, 2007
: Kevin D. Belfield

Page 1of1

It is certified that error appears in the above-identified patent and that said Letters Patent is hereby corrected as shown below:

Col. 1, line 5 should read as follows:
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
This subject invention was made with government support under the National Science Foundation
(ECS-9970078, ECS-0217932, DMR-9975773), The National Research Council (COBASE), the
Research Corporation, and the donors of The Petroleum Research Fund of the American Chemical
Society and the Florida Hospital Gala Endowed Program for Oncological Research Award. The
government has certain rights in this invention.

Signed and Sealed this
First Day of March, 2011

ffa:.1 J:•k~
David J. Kappos
Director of the United States Patent and Trademark Office

